|
|
Today's journal articles
No journal articles today
Do you need further information on any of the agents being evaluated in the trial(s) below? Let us know...
New Clinical Trials
No clinical trials today
Previous Journal Entries
A Controlled, Randomized, Head-to-Head Comparison of the Prolieve Thermodilatation System Versus the Targis System for Benign Prostatic Hyperplasia: Safety, Procedural Tolerability, and Clinical Results.
Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats.
A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladder.
The M2 muscarinic receptor inhibits the development of streptozotocin-induced neuropathy in mouse urinary bladder.
Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial.
The potent synthetic androgens, dimethandrolone (7alpha,11beta - dimethyl - 19 - nortestosterone) and 11beta - methyl - 19 - nortestosterone, do not require 5alpha - reduction to exert their maximal androgenic effects.
Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study.
Randomised, placebo-controlled, crossover trial of sildenafil citrate in the treatment of erectile dysfunction following external beam radiation treatment of prostate cancer.
Overactive Bladder Drugs and Constipation: A Meta-Analysis of Randomized, Placebo-Controlled Trials.
A Protein Tyrosine Kinase Inhibitor, Imatinib Mesylate (Gleevec), Improves Erectile and Vascular Function Secondary to a Reduction of Hyperglycemia in Diabetic Rats.
Intracavernous Delivery of Synthetic Angiopoietin-1 Protein as a Novel Therapeutic Strategy for Erectile Dysfunction in the Type II Diabetic db/db Mouse.
Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.
Application of the nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate for the treatment of endometriosis: an in vitro study.
Etanercept causes regression of endometriotic implants in a rat model.
Udenafil Enhances the Recovery of Erectile Function and Ameliorates the Pathophysiological Consequences of Cavernous Nerve Resection.
A Multicenter, Randomized, Double-blind, Parallel Group Pilot Evaluation of the Efficacy and Safety of Intravesical Sodium Chondroitin Sulfate Versus Vehicle Control in Patients With Interstitial Cystitis/Painful Bladder Syndrome.
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 4-year data from the CombAT study.
1 - (2 - Ethoxyethyl) - 1H - pyrazolo[4,3 - d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors.
Synthesis and structure - activity relationships of 2 - acylamino - 4,6 - diphenylpyridine derivatives as novel antagonists of GPR54.
The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
|
Today's News Items
\"Ovatech™ reports successful completion Phase 2 clinical trial
Training Courses & Meetings
No events listed
Previous News Items
No previous news items today
|
If this icon appears after any of our listed articles, the author is able to provide reprints. Articles denoted by an Licensing Op. icon describe data relevant to licensing opportunities. The report icon, 
, links through to full analyses relating to pharmaceutical/market developments relating to this work
